IHH Healthcare plans to expand its operations in India through its two major hospital chains, Gleneagles and Fortis, according to Group CEO Dr. Prem Kumar Nair. The company aims to grow organically by adding 2,000 beds across its existing hospitals within five years.
IHH solidified its control of Gleneagles about a year ago, allowing for more structured growth plans. While Fortis faces ongoing legal issues, it continues to expand operationally. Nair explained that Fortis’ own financial performance supports its projects, including a recent acquisition of a stake in the diagnostics company Agilus (formerly SRL labs).
Nair stated, “We entered at the right time. Despite challenges with both Gleneagles and Fortis, Gleneagles is now fully owned, and Fortis is growing rapidly”. Fortis and Gleneagles currently have 5,000 beds combined, and the plan to add 2,000 more.
India is poised to become one of IHH’s key markets, with the group already present in 12 of the country’s 28 states. Nair highlighted the potential for further expansion into neighbouring regions and indicated that IHH would consider strategic investments in the diagnostics sector as new hospitals are established.
On managing healthcare operations across 10 countries, Nair said, “We are the most risk-diversified healthcare group globally.” He pointed out that while 80% of healthcare regulations are consistent across countries, involving requirements like registered doctors, trained nurses, and fire-safe infrastructure, the remaining 20% varies by region.
As reported by thehindubusinessline.com, Nair noted that the group’s international presence facilitates global procurement, with a growing portion of consumables being sourced from India.
